Idorsia in talks about potential $440M Asia Pacific licensing deal

Swiss biopharmaceutical company Idorsia Ltd., which has its U.S. headquarters in Radnor, said Tuesday it has entered into exclusive negotiations regarding its operating businesses in the Asia Pacific region.
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.